Literature DB >> 18488217

MSI-H colorectal cancers preferentially retain and expand intraepithelial lymphocytes rather than peripherally derived CD8+ T cells.

Kristi Baker1, William D Foulkes, Jeremy R Jass.   

Abstract

The healthy colorectal mucosa contains many resident intraepithelial lymphocytes (IELs) consisting of partially activated yet hyporesponsive CD8(+) T cells. A predominant feature of colorectal cancers (CRCs) characterized by high levels of microsatellite instability (MSI-H) is heavy infiltration by an intraepithelial population of tumor infiltrating lymphocytes (iTILs). While it has been assumed that these iTILs originate from tumor infiltration by peripheral CD8(+) effector T cells, their origin remains unknown. In light of the phenotypic and functional differences exhibited by IELs and peripheral T cells, elucidation of the precursor population of iTILs in MSI-H CRCs could clarify the role played by these lymphocytes in tumor progression. The aim of the present study was to investigate whether MSI-H CRCs interact differently with IEL- versus peripherally-derived CD8(+) T cells. Using a Transwell assay system to mimic basolateral infiltration of tumor cells by lymphocytes, T cell migration, retention, proliferation and phenotypic alterations were investigated. Results indicate that MSI-H CRCs preferentially retain and expand IEL-derived cells to a greater degree than their microsatellite stable (MSS) counterparts. While MSI-H CRCs also retained more peripherally derived T cells, this number was considerably less than that from the IEL population. While interaction of IELs with either CRC type led to baseline lymphocyte activation, MSS CRCs induced upregulation of additional activation markers on retained IELs compared to MSI-H CRCs. These results suggest that the abundant iTILs present in MSI-H CRCs result from expansion of the preexisting mucosal IEL population and imply a limited prognostic role for iTILs in MSI-H CRC.

Entities:  

Mesh:

Year:  2008        PMID: 18488217     DOI: 10.1007/s00262-008-0534-1

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  7 in total

1.  Systemic Analysis of Predictive Biomarkers for Recurrence in Colorectal Cancer Patients Treated with Curative Surgery.

Authors:  Koichiro Mori; Yuji Toiyama; Susumu Saigusa; Hiroyuki Fujikawa; Junichiro Hiro; Minako Kobayashi; Masaki Ohi; Toshimitsu Araki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 2.  Genotypic and phenotypic signatures to predict immune checkpoint blockade therapy response in patients with colorectal cancer.

Authors:  Xianda Zhao; Audre May; Emil Lou; Subbaya Subramanian
Journal:  Transl Res       Date:  2018-02-12       Impact factor: 7.012

3.  [Differential diagnostics of hereditary colorectal cancer syndromes. The role of pathology].

Authors:  J Rüschoff; E Heinmöller; A Hartmann; R Büttner; T Rau
Journal:  Pathologe       Date:  2010-10       Impact factor: 1.011

4.  Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.

Authors:  Frank A Sinicrope; Rafaela L Rego; Stephen M Ansell; Keith L Knutson; Nathan R Foster; Daniel J Sargent
Journal:  Gastroenterology       Date:  2009-07-03       Impact factor: 22.682

5.  TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.

Authors:  Inti Zlobec; Eva Karamitopoulou; Luigi Terracciano; Salvatore Piscuoglio; Giandomenica Iezzi; Manuele Giuseppe Muraro; Giulio Spagnoli; Kristi Baker; Alexandar Tzankov; Alessandro Lugli
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

6.  Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.

Authors:  John M Carethers; Bhavya Murali; Bing Yang; Ryan T Doctolero; Akihiro Tajima; Ranor Basa; E Julieta Smith; Monte Lee; Ryan Janke; Tina Ngo; Ruth Tejada; Ming Ji; Matthew Kinseth; Betty L Cabrera; Katsumi Miyai; Temitope O Keku; Christopher F Martin; Joseph A Galanko; Robert S Sandler; Kathleen L McGuire
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

7.  Density and distribution of lymphocytes in pretherapeutic rectal cancer and response to neoadjuvant therapy.

Authors:  Sicong Lai; Xiaoying Lou; Xinjuan Fan; Weipeng Sun; Yanhong Deng; Jianping Wang; Yan Huang; Ruoxu Dou
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.